- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
My locations
Active clinical trials
This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype called diffuse cutaneous systemic sclerosis. People with another subtype called limited cutaneous…
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 16 Years - N/A
- Sexes
- All
My research
Top areas of exploration
- Actins , 37 publications
- Amino Acid Sequence , 18 publications
- Microfilament Proteins , 18 publications
- Protein Binding , 13 publications
Research activity
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
My areas of focus
Stories and news
UF Center for Regenerative Medicine recruiting for trial on potential therapy for autoimmune disorders
August 2, 2022
The University of Florida Center for Regenerative Medicine today announced the launch of a clinical trial to test safe dosages of umbilical cord-derived stem…
Division of Rheumatology and Clinical Immunology, +4 more